Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CBO Revised Medicare Rx Estimates Reduce Savings From PBM Techniques

Executive Summary

The Congressional Budget Office is reducing its estimate for the savings impact from PBM cost management techniques under Rep. Thomas' (R-Calif.) Medicare prescription drug plan.

You may also be interested in...



CBO Medicare Rx Costs: Thomas Plan Is $155 Bil. Under House Set-Aside

The House leadership will have approximately $155 bil. to use under this year's budget resolution to enhance its Medicare Rx proposal, according to the Congressional Budget Office's revised cost estimates for drug benefit proposals

CBO Medicare Rx Costs: Thomas Plan Is $155 Bil. Under House Set-Aside

The House leadership will have approximately $155 bil. to use under this year's budget resolution to enhance its Medicare Rx proposal, according to the Congressional Budget Office's revised cost estimates for drug benefit proposals

Medicare Rx Budget To Be $190 Bil. Over Next 10 Years, White House Says

The available funding for a Medicare prescription drug benefit likely will be less than $200 bil. over the next 10 years due to the fiscal constraints outlined by the White House Office of Management & Budget mid-session budget review.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037979

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel